We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
임상 단계 바이오 제약 회사인 Aardvark Therapeutics, Inc.는 대사 질환 치료를 위해 선천적 항상성 경로를 활성화하는 저분자 치료제 개발에 주력하고 있습니다. 이 회사는 2017년에 설립되었으며, 본사는 캘리포니아 샌디에이고에 있습니다.